Article

Condor Software closed a $24 million Series A funding round led by Insight Partners, bringing total funding to $36 million. The AI-powered financial intelligence platform integrates clinical, operational, and financial data for life sciences companies, addressing the inefficiencies of traditional spreadsheet-based financial systems.

With annual pharmaceutical R&D spending at approximately $300 billion, Condor aims to enhance financial clarity and decision-making in trial funding. The funding will accelerate platform expansion and workforce scaling, targeting improved efficiency and automation in clinical trial finance.